awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42392542-673A4579-8111-497A-8188-867C32A6FC25
Q42392542-673A4579-8111-497A-8188-867C32A6FC25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42392542-673A4579-8111-497A-8188-867C32A6FC25
Comment on 'costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib'.
P932
Q42392542-673A4579-8111-497A-8188-867C32A6FC25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42392542-673A4579-8111-497A-8188-867C32A6FC25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83ed90b7b365613b55d524a095de385201d5e842
P932
2967059
http://www.w3.org/2001/XMLSchema#string